AIDS Therapies

Trinidad Strikes Deal With Pharmaceutical Firms For Cheap Drugs

Published in AIDS Weekly, June 4th, 2001

Trinidad's government has worked out a deal with GlaxoSmithKline to provide the Caribbean nation with AIDS drugs at a 90% discounted rate.

GlaxoSmithKline district manager Anthony Whitehall confirmed the London-based company reached the agreement to discount a three-drug cocktail that includes the antiretroviral drug AZT. The drug cocktail began lowering AIDS death rates dramatically five years ago. The breakthrough therapy combined AZT - a nucleoside reverse transcriptase inhibitor - with newer drugs known as protease inhibitors.

There are 17,000 reported cases of HIV infection or AIDS in the two-island nation of 1.3 million people, but the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-06-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry